Drupal.behaviors.print = function(context) {window.print();window.close();}>

Fate Therapeutics Licenses Stem-Cell Modulators for Bone Regeneration from UCLA

July 01, 2009

Fate Therapeutics Licenses Stem-Cell Modulators for Bone Regeneration from UCLA

By Ben Butkus

UCLA becomes at least the eighth university or research institution from which Fate licensed IP to bolster its portfolio of stem cell modulators — small molecules and biologics to modulate cells for therapeutic purposes.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories